GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

>engineered by so few! I think I like
For sure, but the flip side is key man risk: we have plenty
and it demands compensation. I don't mean paying Meade but
the idea that if he keels over we're sorta hosed so our risk
premium is greater than it would be if we had a deeper bench.

As to the productivity of our cadre, just so, a prime reason
to be here, not just for the main dish but also for the side
orders (filtration and purification).